MyAverix Finance
F · Healthcare
SOL-GEL TECHN. IS-10 (4SG)
Biotechnology
SOL-GEL TECHN. IS-10 (4SG) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 4SG
SOL-GEL TECHN. IS-10 (4SG) — FAQ
What is 4SG's P/E ratio?
The price-to-earnings (P/E) ratio for SOL-GEL TECHN. IS-10 (4SG) is 25.00 (data as of 2026-05-23).
Does SOL-GEL TECHN. IS-10 pay a dividend?
Dividend yield is not available in the current snapshot for SOL-GEL TECHN. IS-10 (4SG). Check the MyAverix Finance app for the latest dividend data.
What sector is SOL-GEL TECHN. IS-10 in?
SOL-GEL TECHN. IS-10 (4SG) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 4SG listed on?
4SG is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.